BU-NOT-SET

CONTACT US
The Final Countdown: CDMO focus areas before February 2019
  • Manufacturing
Eyes
Insight
Changing dynamics: the CDMO market in focus
  • Industry trends
Eyes
Insight
Formulation development trends
  • Drug product
Eyes
Insight
One-year countdown to Brexit
  • Industry trends
Eyes
Insight
High throughput screening platform for liquid formulation design
  • Drug product
Man lab
White paper
Could limited access to the EU Hub threaten serialization readiness?
  • Manufacturing
Eyes
Insight
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
  • Drug product
Eyes
Insight
US DSCSA: data standardisation
  • Manufacturing
Eyes
Insight
Developments in high-throughput screening
  • Drug product
Eyes
Insight
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes
Case study
  • Analytical chemistry
  • Drug product
Analytical method development for multivitamin tablets
Insight
  • Drug product
  • Manufacturing
The evolving OSD market: Complexity, capability and collaboration
Insight
  • Drug product
  • Manufacturing
High-potency APIs and the evolving demands of drug development
White paper
  • Drug product
  • Manufacturing
Safely scaling high potency API manufacturing
Insight
  • Drug product
  • Manufacturing
From development insight to manufacturing confidence
Insight
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing RNA Therapeutics